Spruce Biosciences Inc. (SPRB)
NASDAQ: SPRB
· Real-Time Price · USD
8.75
-0.55 (-5.93%)
At close: Jun 09, 2025, 3:57 PM
8.75
0.00%
After-hours: Aug 13, 2025, 08:00 PM EDT
Spruce Biosciences Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -14.04M | -23.56M | -8.67M | -9.18M | -11.63M | -9.95M | -12.35M | -12.82M | -12.79M | -11.14M | -11.4M | -11.87M | -11.76M | -9.18M | -11.45M | -11.77M | -9.89M |
Depreciation & Amortization | 6K | 9K | 10K | 12K | 15K | 16K | 17K | 18K | 19K | 24K | 23K | 6K | 21K | 20K | 18K | 17K | 13K |
Stock-Based Compensation | 544K | 961K | 1.14M | 1.69M | 1.56M | 1.22M | 1.12M | 1.22M | 1.06M | 802K | 783K | 905K | 1.14M | 797K | 1.03M | 1.01M | 1.12M |
Other Working Capital | n/a | 2.35M | -2.88M | -2.48M | -3.53M | -2.67M | -3.18M | 16.28M | 13.02M | 676K | 960K | -145K | -1.3M | -893K | 837K | 972K | -28K |
Other Non-Cash Items | n/a | 64K | 62K | 63K | 3.09M | 1.07M | 57K | 56K | -123K | -699K | 85K | 84K | 138K | 80K | 78K | 78K | 77K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | -1.07M | -138K | -249K | n/a | n/a | n/a | n/a | n/a | 61K | 57K | 3K | n/a |
Change in Working Capital | n/a | 1.85M | -1.76M | -3.69M | -4.97M | -2.49M | -973K | 13.77M | 45K | -721K | 1.93M | 1.28M | -1.36M | -1.57M | 2.67M | 972K | -110K |
Operating Cash Flow | -12.73M | -20.68M | -9.22M | -11.11M | -14.96M | -11.21M | -12.27M | 1.99M | -11.79M | -11.74M | -8.58M | -9.54M | -11.83M | -9.8M | -7.6M | -9.69M | -8.79M |
Capital Expenditures | n/a | n/a | n/a | n/a | n/a | n/a | -7K | n/a | n/a | -6K | -2K | -6K | n/a | -6K | -65K | -3K | -19K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -4M | n/a | n/a | -60.83M | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -11.88M | -2.93M | -20.89M | -1.99M | -10.99M | -5.98M | -12.27M | -60.83M | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | 9.3M | 14M | 22M | 22.36M | 17.5M | 4M | 35.5M | 3.5M | 121K | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | 9.3M | 14M | 22M | 10.48M | 6K | 4M | 33.51M | 3.5M | 60.71M | -12.27M | -60.83M | n/a |
Investing Cash Flow | n/a | n/a | n/a | n/a | n/a | 9.3M | 13.99M | 22M | 10.48M | 14.57M | -16.89M | 33.51M | -7.49M | -5.98M | -12.34M | -60.83M | -19K |
Debt Repayment | n/a | -406K | -405K | -406K | -405K | -406K | -405K | -406K | -405K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 220K |
Common Stock Repurchased | n/a | n/a | n/a | -11K | -2K | -217K | n/a | -71K | n/a | 76K | -40K | n/a | n/a | 134K | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -411K | -219K | n/a | 41K | 178K | 71K | n/a | -26K | -2.68M | 36K | -50K | -99K | -88K | 167K | 17K | 176K | 63K |
Financial Cash Flow | -411K | -625K | -405K | -365K | -227K | -552K | -405K | -432K | 50.53M | 36K | -90K | -99K | -88K | 167K | 17K | 176K | 283K |
Net Cash Flow | -13.14M | -21.3M | -9.63M | -11.47M | -15.19M | -2.46M | 1.32M | 23.56M | 49.22M | 2.87M | -25.56M | 23.87M | -19.41M | -15.62M | -19.91M | -70.35M | -8.52M |
Free Cash Flow | -12.73M | -20.68M | -9.22M | -11.11M | -14.96M | -11.21M | -12.28M | 1.99M | -11.79M | -11.74M | -8.58M | -9.55M | -11.83M | -9.8M | -7.66M | -9.7M | -8.81M |